Andrea H. Epperly

1.2k total citations
11 papers, 728 citations indexed

About

Andrea H. Epperly is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Andrea H. Epperly has authored 11 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Andrea H. Epperly's work include Angiogenesis and VEGF in Cancer (4 papers), Receptor Mechanisms and Signaling (3 papers) and HER2/EGFR in Cancer Research (3 papers). Andrea H. Epperly is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Receptor Mechanisms and Signaling (3 papers) and HER2/EGFR in Cancer Research (3 papers). Andrea H. Epperly collaborates with scholars based in United States, United Kingdom and Netherlands. Andrea H. Epperly's co-authors include Mui Cheung, Jeffrey A. Stafford, Deirdre K. Luttrell, Renae M. Crosby, Jennifer H. Johnson, Rakesh Kumar, L.E. Harrington, James A. Onori, Charles G. Miller and Teresa M. Hopper and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Andrea H. Epperly

11 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea H. Epperly United States	9	371	248	239	126	115	11	728
Ming‐Chih Crouthamel United States	9	526 1.4×	266 1.1×	264 1.1×	51 0.4×	125 1.1×	10	953
Lianshan Zhang China	18	352 0.9×	339 1.4×	170 0.7×	107 0.8×	80 0.7×	38	843
David A. Rewolinski United States	6	355 1.0×	209 0.8×	249 1.0×	74 0.6×	136 1.2×	7	638
Nicola Dobbs United Kingdom	15	367 1.0×	378 1.5×	95 0.4×	118 0.9×	122 1.1×	26	899
Julie C. Lougheed United States	12	571 1.5×	259 1.0×	168 0.7×	63 0.5×	109 0.9×	16	998
Charles Karan United States	16	535 1.4×	125 0.5×	188 0.8×	84 0.7×	215 1.9×	32	940
Sadao Kuromitsu Japan	19	500 1.3×	214 0.9×	195 0.8×	118 0.9×	61 0.5×	39	1.1k
Loredana Urso Italy	20	592 1.6×	394 1.6×	244 1.0×	116 0.9×	377 3.3×	46	1.2k
Krikor Bijian Canada	22	553 1.5×	162 0.7×	83 0.3×	122 1.0×	166 1.4×	40	1.2k

Countries citing papers authored by Andrea H. Epperly

Since Specialization

Citations

This map shows the geographic impact of Andrea H. Epperly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea H. Epperly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea H. Epperly more than expected).

Fields of papers citing papers by Andrea H. Epperly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea H. Epperly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea H. Epperly. The network helps show where Andrea H. Epperly may publish in the future.

Co-authorship network of co-authors of Andrea H. Epperly

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea H. Epperly. A scholar is included among the top collaborators of Andrea H. Epperly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea H. Epperly. Andrea H. Epperly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Evans, Karen A., Barry G. Shearer, David D. Wisnoski, et al.. (2011). Phenoxyacetic acids as PPARδ partial agonists: Synthesis, optimization, and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 21(8). 2345–2350. 8 indexed citations

Ignar, Diane M., Aaron S. Goetz, Joyce A. Boucheron, et al.. (2011). Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 339(1). 24–34. 41 indexed citations

Zhang, Cunyu, Susan M. Westaway, Jason D. Speake, et al.. (2010). Tetrahydroquinoline derivatives as opioid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 670–676. 7 indexed citations

Evans, Karen A., Frank T. Coppo, Todd L. Graybill, et al.. (2008). Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4068–4071. 9 indexed citations

Cheung, Mui, Philip A. Harris, Stanley D. Chamberlain, et al.. (2008). The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5428–5430. 36 indexed citations

Cheung, Mui, Kevin W. Kuntz, James M. Salovich, et al.. (2008). Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1. Bioorganic & Medicinal Chemistry Letters. 18(23). 6214–6217. 9 indexed citations

Emmitte, Kyle A., C. Webb Andrews, Ronda G. Davis‐Ward, et al.. (2008). Discovery of thiophene inhibitors of polo-like kinase. Bioorganic & Medicinal Chemistry Letters. 19(3). 1018–1021. 33 indexed citations

Kumar, Rakesh, Victoria B. Knick, Sharon K. Rudolph, et al.. (2007). Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Molecular Cancer Therapeutics. 6(7). 2012–2021. 423 indexed citations

Harris, Philip A., Mui Cheung, R. Hunter, et al.. (2005). Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors. Journal of Medicinal Chemistry. 48(5). 1610–1619. 117 indexed citations

10.

Kumar, Rakesh, L.E. Harrington, Teresa M. Hopper, et al.. (2005). Correlation of anti-tumor and anti-angiogenic activity of VEGFR inhibitors with inhibition of VEGFR2 phosphorylation in mice. Journal of Clinical Oncology. 23(16_suppl). 9537–9537. 10 indexed citations

11.

Dev, I K, Ronna E. Dornsife, Teresa M. Hopper, et al.. (2004). Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models. British Journal of Cancer. 91(7). 1391–1398. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact